⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for abiraterone

Every month we try and update this database with for abiraterone cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Evaluation of Safety and Efficacy of KPG-121 Plus Enzalutamide, Abiraterone or Apalutamide in CRPC PatientsNCT03569280
Castration-Resi...
Enzalutamide or...
18 Years - Kangpu Biopharmaceuticals, Ltd.
Abiraterone Acetate for Castrate Resistant Prostate CancerNCT01961843
Prostate Cancer
Abiraterone
Prednisone
18 Years - Massachusetts General Hospital
Enzalutamide vs. Abiraterone in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC)NCT05520138
Prostatic Neopl...
Enzalutamide
Abiraterone ace...
18 Years - Pfizer
A Study of Abiraterone Acetate (JNJ-212082) and Prednisolone in Patients With Advanced Prostate CancerNCT01685983
Prostate Cancer
Abiraterone ace...
Prednisolone
18 Years - Janssen Research & Development, LLC
Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate CancerNCT01995058
Prostate Cancer
Castration Resi...
Prostatic Neopl...
cabozantinib
abiraterone
prednisone
18 Years - Exelixis
A Study to Determine the Short-Term Safety of Continuous Dosing of Abiraterone Acetate and Prednisone in Modified Fasting and Fed States to Patients With Metastatic Castration-Resistant Prostate CancerNCT01424930
Prostate Neopla...
Prostate Cancer
Abiraterone
Prednisone
18 Years - Janssen-Ortho Inc., Canada
Cabazitaxel vs Abiraterone or Enzalutamide in Patients With Poor Prognosis Metastatic Castration-resistant Prostate CancerNCT02254785
Metastatic Cast...
cabazitaxel
Abiraterone
Enzalutamide 16...
18 Years - British Columbia Cancer Agency
Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate CancerNCT04262154
Metastatic Pros...
Atezolizumab
Abiraterone
Prednisone
GnRH analog
Stereotactic Bo...
Enzalutamide
Follow up
18 Years - Memorial Sloan Kettering Cancer Center
Docetaxel Versus Abiraterone as First-line Treatment in mCRPC Patients With Intraductal Carcinoma of the ProstateNCT03356444
Prostate Cancer
Castration-resi...
Drug
Abiraterone Ace...
Docetaxel
40 Years - West China Hospital
Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate CancerNCT01995058
Prostate Cancer
Castration Resi...
Prostatic Neopl...
cabozantinib
abiraterone
prednisone
18 Years - Exelixis
Vudalimab (XmAb20717) in Combination With Standard of Care Treatment in Patients With Metastatic Castration Sensitive Prostate CancerNCT05733351
Castration-Sens...
Metastatic Pros...
Stage IVB Prost...
Abiraterone
Biospecimen Col...
Bone Scan
Computed Tomogr...
Docetaxel
Enzalutamide
FDG-Positron Em...
Magnetic Resona...
PSMA PET Scan
Vudalimab
18 Years - Emory University
Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel ChemotherapyNCT01485861
Prostate Cancer
Abiraterone
Apitolisib
Ipatasertib
Placebo
Prednisone
Prednisolone
18 Years - Genentech, Inc.
Rezvilutamide Plus Abiraterone for Metastatic Hormone-sensitive Prostate CancerNCT06134271
Metastatic Horm...
Rezvilutamide
Rezvilutamide p...
Continue previo...
18 Years - First Hospital of China Medical University
Radiotherapy Plus Hormone Therapy in Biochemically-relapsing Prostate Cancer Patients Following SurgeryNCT01780220
Biochemically-r...
Abiraterone
18 Years - UNICANCER
A Study of Pamiparib Combined With Abiraterone Acetate in Neoadjuvant Treatment of Prostate CancerNCT05376722
Neoadjuvant The...
pamiparib
abiraterone
prednisone
18 Years - 80 YearsThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Study Evaluating mCRPC Treatment Using PSMA [Lu-177]-PNT2002 Therapy After Second-line Hormonal TreatmentNCT04647526
Metastatic Cast...
[Lu-177]-PNT200...
Abiraterone
Enzalutamide
18 Years - POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company
Abiraterone With Discontinuation of Gonadotropin-Releasing Hormone Analogues in Metastatic Prostate CancerNCT03565835
Prostatic Neopl...
Abiraterone Ace...
Prednisone
18 Years - Montefiore Medical Center
Study of Abiraterone Acetate Plus ADT Versus APALUTAMIDE Versus Abiraterone and APALUTAMIDE in Patients With Advanced Prostate Cancer With Non-castrate Testosterone LevelsNCT02867020
Prostate Cancer
Apalutamide
Abiraterone
ADT
Prednisone
18 Years - Latin American Cooperative Oncology Group
A Study of Abiraterone in Combination With SHR3162 in the Treatment of mCRPCNCT04108247
Prostate Cancer...
Abiraterone+SHR...
18 Years - Jiangsu HengRui Medicine Co., Ltd.
CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and AbirateroneNCT03934840
Prostate Cancer
Cabazitaxel
Carboplatin
Abiraterone
Prednisone
18 Years - Masonic Cancer Center, University of Minnesota
Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET StudyNCT06430411
Prostate Cancer...
Prostate Cancer...
Prostate Cancer
Prostate Neopla...
Oligometastatic...
Oligometastasis
Radical prostat...
Prostate irradi...
Surgical metast...
Irradiation of ...
Abiraterone ace...
Enzalutamide
Darolutamide
Apalutamide
Docetaxel
Lutetium-PSMA
Androgen depriv...
18 Years - 80 YearsMedical University of Vienna
A Multi-centre Study to Assess the Safety, Tolerability, and Pharmacokinetics of Capivasertib (AZD5363) in Combination With Novel Agents in Patients With Metastatic Prostate CancerNCT04087174
Prostate Cancer
Capivasertib
Enzalutamide
Abiraterone
18 Years - 130 YearsAstraZeneca
Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in FinlandNCT05701007
Metastatic Cast...
Metastatic Cast...
abiraterone
enzalutamide
docetaxel
apalutamide
cabazitaxel
Radium-223
Lutetium-177
degarelix
goserelin
leuprorelin
triptorelin
18 Years - Pfizer
Denosumab Plus Enzalutamide, Abiraterone and Prednisone Compared to Denosumab Plus Enzalutamide Alone for Men With Castrate Resistant Prostate Cancer (CRPC) With Bone MetastasesNCT02758132
Prostate Cancer
Denosumab
Enzalutamide
Abiraterone
Prednisone
18 Years - University of Hawaii
Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC StudyNCT04175431
Prostate Adenoc...
Positron Emissi...
Lymphadenectomy
Radiation Thera...
Abiraterone Ace...
Prednisone
Computed Tomogr...
Abiraterone
PSMA PET Scan
18 Years - University of Washington
Improving Bio-availability of the Expensive Oral Oncolytic Drug Abiraterone by Food IntakeNCT02883166
Prostate Cancer
abiraterone
18 Years - Radboud University Medical Center
A Study to Learn About Novel Hormonal Therapies in People With Metastatic Castration-Sensitive Prostate Cancer (mCSPC)NCT06072196
Prostatic Neopl...
Novel hormonal ...
65 Years - Pfizer
Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate CancerNCT04666129
Metastatic Cast...
Metastatic Cast...
Non-Metastatic ...
Relugolix
Abiraterone
Prednisone
Methylprednisol...
Apalutamide
Docetaxel
18 Years - Sumitomo Pharma Switzerland GmbH
Neoadjuvant Androgen Deprivation Therapy Plus Abiraterone With or Without Apalutamide for High-Risk Prostate CancerNCT02789878
Prostate Cancer
Goserelin
Prednisone
Abiraterone
Apalutamide
18 Years - 80 YearsInstituto do Cancer do Estado de São Paulo
Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC StageNCT05627752
Prostate Cancer
Castrate Resist...
Enzalutamide 40...
Docetaxel injec...
18 Years - 75 YearsZhongnan Hospital
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate CancerNCT04221542
Prostate Cancer
AMG 509
Abiraterone
Enzalutamide
18 Years - Amgen
XL-184+Abiraterone in Post-Chemo CRPCNCT01574937
Prostate Cancer
Cabozantinib
Abiraterone
18 Years - Dana-Farber Cancer Institute
Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate CancerNCT03511196
Prostate Cancer
Stage IV Prosta...
Advanced Prosta...
Adenocarcinoma ...
Adaptive Androg...
Abiraterone
Prednisone
18 Years - H. Lee Moffitt Cancer Center and Research Institute
Evaluation of Safety and Efficacy of KPG-121 Plus Enzalutamide, Abiraterone or Apalutamide in CRPC PatientsNCT03569280
Castration-Resi...
Enzalutamide or...
18 Years - Kangpu Biopharmaceuticals, Ltd.
CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and AbirateroneNCT03934840
Prostate Cancer
Cabazitaxel
Carboplatin
Abiraterone
Prednisone
18 Years - Masonic Cancer Center, University of Minnesota
Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET StudyNCT06430411
Prostate Cancer...
Prostate Cancer...
Prostate Cancer
Prostate Neopla...
Oligometastatic...
Oligometastasis
Radical prostat...
Prostate irradi...
Surgical metast...
Irradiation of ...
Abiraterone ace...
Enzalutamide
Darolutamide
Apalutamide
Docetaxel
Lutetium-PSMA
Androgen depriv...
18 Years - 80 YearsMedical University of Vienna
A Study of Abiraterone Acetate (JNJ-212082) and Prednisolone in Patients With Advanced Prostate CancerNCT01685983
Prostate Cancer
Abiraterone ace...
Prednisolone
18 Years - Janssen Research & Development, LLC
Systemic and Tumor-Directed Therapy for Oligometastatic Prostate CancerNCT03298087
Newly Diagnosed...
radical prostat...
stereotactic bo...
Leuprolide
apalutamide
abiraterone
18 Years - VA Office of Research and Development
XL-184+Abiraterone in Post-Chemo CRPCNCT01574937
Prostate Cancer
Cabozantinib
Abiraterone
18 Years - Dana-Farber Cancer Institute
A Study to Evaluate Enzalutamide After Abiraterone in Metastatic Castration-Resistant Prostate CancerNCT02116582
Metastatic Cast...
Enzalutamide
18 Years - Astellas Pharma Inc
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of SOL-804 in Healthy Male SubjectsNCT06014853
Prostate Cancer
SOL-804-F
Zytiga
19 Years - 50 YearsBukwang Pharmaceutical
A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer Who Have Received DocetaxelNCT01795703
Prostate Cancer
Abiraterone
Prednisolone
20 Years - Janssen Research & Development, LLC
RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study)NCT02090114
Prostate Cancer
Testosterone cy...
Testosterone En...
Abiraterone ace...
Enzalutamide
18 Years - Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Study of XL102 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (QUARTZ-101)NCT04726332
Neoplasm Malign...
Epithelial Ovar...
Triple Negative...
Hormone Recepto...
Metastatic Cast...
XL102
Fulvestrant
Abiraterone
Prednisone
18 Years - Exelixis
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of SOL-804 in Healthy Male SubjectsNCT06014853
Prostate Cancer
SOL-804-F
Zytiga
19 Years - 50 YearsBukwang Pharmaceutical
A Multi-centre Study to Assess the Safety, Tolerability, and Pharmacokinetics of Capivasertib (AZD5363) in Combination With Novel Agents in Patients With Metastatic Prostate CancerNCT04087174
Prostate Cancer
Capivasertib
Enzalutamide
Abiraterone
18 Years - 130 YearsAstraZeneca
Biomarker Study of in Men With PSA Progression on Abi for CR or CS PC (Bio-STAMP)NCT05705700
Prostate Cancer
Dutasteride
Abiraterone
18 Years - Masonic Cancer Center, University of Minnesota
Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug EfficacyNCT00268476
Prostate Cancer
Celecoxib
Docetaxel
Prednisolone
ADT
Zoledronic Acid
Abiraterone
Radiotherapy to...
Enzalutamide
Metformin
Transdermal Oes...
- 120 YearsMedical Research Council
Analysis of Next Generation PET and Liquid Biopsy to Monitor mCRPC Treated With Abiraterone: ANGELA TrialNCT05188911
Prostate Cancer
Castration-resi...
Metastatic Dise...
Abiraterone
Prednisone
Androgen depriv...
18 Years - 85 YearsFudan University
Dose-Finding Study of Afuresertib Administered in Combination With Either Enzalutamide or AibrateroneNCT02380313
Cancer
Afuresertib
Enzalutamide
Abiraterone
Prednisone
18 Years - GlaxoSmithKline
Randomized Phase II Study of Salvage XRT + ADT +/- Abiraterone and Apalutamide for Rising PSA After RP (FORMULA-509)NCT03141671
Prostate Cancer
GnRH
Bicalutamide
Salvage radiati...
Abiraterone
Prednisone
Apalutamide
18 Years - 95 YearsDana-Farber Cancer Institute
AASUR in High Risk Prostate CancerNCT02772588
Prostate Cancer
ARN-509
Abiraterone
Leuprolide
stereotactic, u...
18 Years - Memorial Sloan Kettering Cancer Center
Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate CancerNCT04666129
Metastatic Cast...
Metastatic Cast...
Non-Metastatic ...
Relugolix
Abiraterone
Prednisone
Methylprednisol...
Apalutamide
Docetaxel
18 Years - Sumitomo Pharma Switzerland GmbH
A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer Who Have Received DocetaxelNCT01795703
Prostate Cancer
Abiraterone
Prednisolone
20 Years - Janssen Research & Development, LLC
Navitoclax and Abiraterone Acetate With or Without Hydroxychloroquine in Treating Patients With Progressive Metastatic Castrate Refractory Prostate CancerNCT01828476
Prostate Cancer
Abiraterone
ABT-263
Hydroxychloroqu...
18 Years - Rutgers, The State University of New Jersey
Sequencing Abiraterone and Enzalutamide in mCRPCNCT02125357
Metastatic Cast...
Abiraterone ace...
Enzalutamide
18 Years - British Columbia Cancer Agency
A Study to Learn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castration-resistant Prostate CancerNCT05968599
Prostatic Neopl...
Enzalutamide
Abiraterone ace...
18 Years - Pfizer
Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate CancerNCT04262154
Metastatic Pros...
Atezolizumab
Abiraterone
Prednisone
GnRH analog
Stereotactic Bo...
Enzalutamide
Follow up
18 Years - Memorial Sloan Kettering Cancer Center
Dose Escalation and Dose Expansion Study of GSK525762 in Combination With Androgen Deprivation Therapy in Participants With Castrate-resistant Prostate CancerNCT03150056
Solid Tumours
GSK525762
Abiraterone
Enzalutamide
Prednisone
18 Years - GlaxoSmithKline
Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate CancerNCT01949337
Adenocarcinoma ...
Hormone-resista...
Recurrent Prost...
Stage IV Prosta...
enzalutamide
abiraterone
prednisone
18 Years - Alliance for Clinical Trials in Oncology
AMG 386 and Abiraterone for Advanced Prostate CancerNCT01553188
Prostatic Neopl...
Prostate Cancer
Neoplasm, Prost...
Neoplasm,Prosta...
AMG 386
Abiraterone
Prednisone
18 Years - 100 YearsNational Institutes of Health Clinical Center (CC)
Optimal Sequencing of Treatment Options for Poor Risk mCRPC Previously Treated With DocetaxelNCT03295565
Prostate Cancer...
Metastasis
Cabazitaxel
Abiraterone
Enzalutamide
18 Years - The Netherlands Cancer Institute
Micro RNAs to Predict Response to Androgen Deprivation TherapyNCT02366494
Prostate Cancer
Bicalutamide
Leuprolide
Goserelin
Triptorelin
Docetaxel
Abiraterone
Apalutamide
Enzalutamide
21 Years - 85 YearsMedical College of Wisconsin
BKM120+Abiraterone Acetate for Metastatic CRPCNCT01741753
Prostate Cancer
BKM120
Abiraterone
Prednisone
18 Years - Dana-Farber Cancer Institute
Abiraterone Acetate for Castrate Resistant Prostate CancerNCT01961843
Prostate Cancer
Abiraterone
Prednisone
18 Years - Massachusetts General Hospital
Enzalutamide vs. Abiraterone in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC)NCT05520138
Prostatic Neopl...
Enzalutamide
Abiraterone ace...
18 Years - Pfizer
A Study of Pamiparib Combined With Abiraterone Acetate in Neoadjuvant Treatment of Prostate CancerNCT05376722
Neoadjuvant The...
pamiparib
abiraterone
prednisone
18 Years - 80 YearsThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and AbirateroneNCT03934840
Prostate Cancer
Cabazitaxel
Carboplatin
Abiraterone
Prednisone
18 Years - Masonic Cancer Center, University of Minnesota
Stereotactic Body Radiation Therapy Plus Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy for Treatment of Metastatic, Recurrent Hormone-Sensitive Prostate Cancer, DIVINE TrialNCT06378866
Recurrent Castr...
Stage IVB Prost...
Recurrent Prost...
Castration-resi...
Abiraterone
Apalutamide
Biospecimen Col...
Bone Scan
Computed Tomogr...
Darolutamide
Degarelix
Enzalutamide
Goserelin
Histrelin
Leuprolide
Magnetic Resona...
Patient Observa...
Positron Emissi...
Prednisone
Questionnaire A...
Relugolix
Stereotactic Bo...
Triptorelin
18 Years - Mayo Clinic
Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate CancerNCT06173362
Advanced Prosta...
Stage III Prost...
Stage IV Prosta...
Abiraterone
Biospecimen Col...
Darolutamide
Prednisone
18 Years - University of California, Davis
Study to Assess Abivertinib in Combination With Abiraterone in Metastatic Castration Resistant Prostate CancerNCT05361915
Prostate Cancer
Prostate Cancer...
Abivertinib
Abiraterone
18 Years - Sorrento Therapeutics, Inc.
Efficacy of Rotations Between Abiraterone Acetate and Apalutamide in mCRPC PatientsNCT03173859
Prostatic Neopl...
Abiraterone
Apalutamide
18 Years - University of Athens
Descriptive Analysis of Clinical Outcomes in Patients With Prostate Gland Cancer, Which Spreads to Other Parts of the Body, Who Were Treated First With Novel Anti-hormone Therapy Followed by a Second Line Treatment With Novel Anti-Hormone Therapy or RadIum-223 (Xofigo).NCT03896984
Metastatic Cast...
Radium-223 (Xof...
Abiraterone
Enzalutamide
- Bayer
Abiraterone With Discontinuation of Gonadotropin-Releasing Hormone Analogues in Metastatic Prostate CancerNCT03565835
Prostatic Neopl...
Abiraterone Ace...
Prednisone
18 Years - Montefiore Medical Center
Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using Multiparametric MRI and 18FDCFPyL PET/CT in Newly Diagnosed Prostate CancerNCT03860987
Castrate Sensit...
goserelin
Enzalutamide
Abiraterone
18F-DCFPyL
Prednisone
Radical Prostat...
18 Years - National Institutes of Health Clinical Center (CC)
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate CancerNCT03678025
Castration Leve...
Metastatic Pros...
Stage IV Prosta...
Stage IVA Prost...
Stage IVB Prost...
Abiraterone
Bicalutamide
Degarelix
Docetaxel
Flutamide
Goserelin Aceta...
Histrelin Aceta...
Leuprolide Acet...
Nilutamide
Orchiectomy
Prednisone
Quality-of-Life...
Radiation Thera...
Radical Prostat...
Triptorelin
18 Years - SWOG Cancer Research Network
Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON)NCT04748042
Prostate Cancer
Castrate Sensit...
Oligometastatic...
Abiraterone
Prednisone
External Beam R...
Androgen Depriv...
Olaparib
18 Years - University of Michigan Rogel Cancer Center
Abiraterone With Discontinuation of Gonadotropin-Releasing Hormone Analogues in Metastatic Prostate CancerNCT03565835
Prostatic Neopl...
Abiraterone Ace...
Prednisone
18 Years - Montefiore Medical Center
Safety Study of Continued Enzalutamide Treatment In Prostate Cancer PatientsNCT01995513
Prostate Cancer
Enzalutamide
Abiraterone
Placebo for Enz...
Prednisone
18 Years - Pfizer
Ph II Study to Evaluate Olaparib With Abiraterone in Treating Metastatic Castration Resistant Prostate Cancer.NCT01972217
Metastatic Cast...
Olaparib
Placebo
Abiraterone
Prednisone or p...
18 Years - 130 YearsAstraZeneca
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: